Elite Penny Stocks To Own In October 2026

Rising interest rates are putting pressure on weaker borrowers, and some heavily indebted AI infrastructure companies now face what analysts call a potential “death spiral” if revenues cannot cover funding costs. When easy money dries up, quality matters. That is where financially healthier low-priced stocks can become interesting for investors looking for growth at a discount. This article highlights three such under the radar opportunities from our penny stock universe.

The three stocks highlighted here offer a compelling starting point if you want exposure to lower risk early-stage businesses with an emphasis on financial strength. However, if you want the standouts, these 7 elite penny stocks are the most outstanding.

Nuvation Bio (NUVB)

Overview: Nuvation Bio is a clinical-stage oncology company developing targeted cancer drugs, led by IBTROZI for ROS1+ lung cancer and safusidenib for IDH1-mutant brain tumors. This aligns closely with the screener’s focus on financially disciplined, late-stage penny stocks.

Operations: Nuvation Bio generates about $169.9 million from oncology development activities, mainly across the United States, China and Japan.

Market Cap: $1.6b

Nuvation Bio matters for this financially fit penny stock screen because IBTROZI and safusidenib give it late-stage cancer assets that can support a more resilient balance sheet while still trading at a low share price.

"IBTROZI is rapidly emerging as the preferred therapy in ROS1 positive non small cell lung cancer, with best in class durability, strong brain penetration and growing first line use."

What happens to Nuvation Bio’s earnings power if one unresolved pressure on long term pricing and access breaks in its favor?

If that pricing overhang eases, read the full narrative for Nuvation Bio to see how Nuvation Bio’s story could accelerate beyond this single oncology data point.

Grab Holdings (GRAB)

Overview: Grab Holdings runs a Southeast Asian superapp for transport, food, parcel delivery and digital finance. GrabFin’s lending and PayLater tools link the platform directly to consumer and merchant credit quality.

Operations: Grab generates about US$3.7b in revenue, led by Deliveries at US$1,987 million, Mobility at US$1,310 million and Financial Services at US$430 million.

Market Cap: US$11.4b

Grab Holdings matters for the Financially Fit Penny Stocks screen because its GrabFin loans and PayLater products tie superapp usage directly to borrower health and cash generation, giving investors exposure to a credit-focused engine inside a diversified, low-priced platform.

"Financial Services may eventually become Grab's second economic engine. Revenue there increased 59%, while the segment's adjusted EBITDA loss narrowed from $26 million to $15 million."

What happens to Grab’s potential earnings quality if one unseen pressure on free cash flow and credit costs resolves in the right direction?

If that pressure eases and cash generation starts to decouple from funding costs, the full narrative for Grab Holdings explains how Grab Holdings' story could accelerate from here.

Under Armour (UAA)

Overview: Under Armour designs and sells performance apparel, footwear and accessories worldwide, with outlet and clearance channels linking it to this financially fit penny stock theme.

Operations: Under Armour generates about $2.8b in North America, $1.2b in EMEA, $708 million in Asia-Pacific and $238 million in Latin America.

Market Cap: $2.0b

Under Armour fits this screener because a low share price meets a globally recognized performance brand that still pushes large volumes through value-focused outlet and factory channels.

"The planned further 25% SKU reduction over the next 18 months, on top of the 25% cut already completed, is creating room for Under Armour to concentrate demand into fewer, higher velocity products like HeatGear, ColdGear, Velociti and Bouncy Tee. This can support higher average selling prices and mix driven gross margin and earnings uplift as the assortment simplification flows through the P&L."

The real swing factor for investors is what happens if one quiet shift in pricing power and full price sell through firmly takes hold.

If that shift takes hold, read the full narrative for Under Armour to see how Under Armour’s outlet muscle and pricing power could be quietly resetting expectations.

Seeking Alternatives Before The Crowd?

Fresh breakouts and quiet momentum can be recognized quickly once they become widely followed. Explore these under the radar ideas while they may still offer differentiated opportunities.

• Target resilient balance sheets by scanning the curated list of solid balance sheet and fundamentals (24 results).
• Spot early moves in gold producers while they are still under the radar with the focused 35 elite gold producer stocks.
• Track the build out of AI infrastructure by following the hand picked 55 AI infrastructure stocks.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com